Antares Pharma, Inc. (AIS) - Product Pipeline Analysis

Antares Pharma, Inc. (AIS) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide39 Pages Price :
$ 750

Antares Pharma, Inc. (Antares Pharma) is a specialty pharmaceutical company that focuses on the self-injection pharmaceutical drugs and technologies and topical gel-based products. The company is focused on topical gel-based products and self-injection pharmaceutical products and technologies. The company has developed three proprietary platforms. Its subcutaneous and intramuscular injection technology platform consists of Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors while its gel-based platform consists of Anturol, for the treatment of OAB (over active bladder) and Elestrin (estradiol gel) used to treat vasomotor symptoms associated with menopause. Antares Pharma applies its drug delivery systems in alliance with pharmaceutical partners to enhance its partners\' drug compounds. It has multiple development partnerships with leading pharmaceutical companies. The company\'s parenteral products division is located in Minneapolis ,Minnesota. Antares Pharma is headquartered in Ewing, New Jersey, the US.

Antares Pharma\'s strategy is to pursue oppurtunities in device master fillings (MAF) by seeking approvals of drug/delivery combinations from the FDA.

This report is a source for data, analysis and actionable intelligence on the Antares Pharma, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Antares Pharma, Inc. - Business Description 5

Key Facts 6
Antares Pharma, Inc. - Major Products and Services 7
Antares Pharma, Inc. Pipeline Products by Equipment Type 8
Antares Pharma, Inc. Pipeline Products by Development Stage 10
Antares Pharma, Inc. Pipeline Products by Therapy Area 12
Antares Pharma, Inc. Pipeline Products by Trial Phase 14
Antares Pharma, Inc. Pipeline Products by Milestone Summary 15
Pen 1 17
Pen 1 Product Status 17
Pen 1 Product Description 17
Pen 2 18
Pen 2 Product Status 18
Pen 2 Product Description 18
Vibex EPI 19
Vibex EPI Product Status 19
Vibex EPI Product Description 19
VIBEX MTX 20
VIBEX MTX Product Status 20
VIBEX MTX Product Description 20
VIBEX MTX Product Milestone 20
VIBEX MTX Clinical Trial 21
VIBEX MTX Product Patent Details 23
Vibex QST 27
Vibex QST Product Status 27
Vibex QST Product Description 27
Vibex QST Product Milestone 27
Vibex QST Product Patent Details 28
Antares Pharma, Inc. - Key Competitors 29
Antares Pharma, Inc. - Key Employees 30
Antares Pharma, Inc. - Key Employee Biographies 31
Antares Pharma, Inc. - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Antares Pharma, Inc., Recent Developments 33
Aug 08, 2012: Antares Pharma Reports Revenue Of $4.5m For Q2 2012 33
Jun 06, 2012: Antares Pharma Announces Move To NASDAQ Stock Market 33
May 08, 2012: Antares Pharma Reports Revenue Of $6.9m In Q1 2012 33
Apr 26, 2012: Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva And Meridian Medical 34
Mar 12, 2012: Antares Pharma Reports Revenue Of $5.4m In Q4 2011 34
Feb 27, 2012: Antares Pharma Elects John Howarth As Vice President, Corporate Affairs 35
Nov 08, 2011: Antares Pharma Reports Revenue Of $3.9m In Q3 2011 35
Oct 04, 2011: Antares Pharma Receives US Patent For VIBEX Injector Technology 36
Aug 08, 2011: Antares Pharma Reports Product Sales Of $2.2m In Q2 2011 36
May 09, 2011: Antares Pharma Reports Product Sales Of $1.4m In Q1 2011 37

Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Table


Antares Pharma, Inc., Key Facts 1
Antares Pharma, Inc. Key Pipeline Products by Equipment Type 1
Antares Pharma, Inc. Key Pipeline Products by Therapy Area 1
Antares Pharma, Inc. Key Pipeline Products by Development Stage 1
Antares Pharma, Inc. Key Pipeline Products by Trial Phase 1
Antares Pharma, Inc., Key Facts 6
Antares Pharma, Inc., Major Products and Services 7
Antares Pharma, Inc. Number of Pipeline Products by Equipment Type 8
Antares Pharma, Inc. Pipeline Products by Equipment Type 9
Antares Pharma, Inc. Number of Pipeline Products by Development Stage 10
Antares Pharma, Inc. Pipeline Products by Development Stage 11
Antares Pharma, Inc. Number of Pipeline Products by Therapy Area 12
Antares Pharma, Inc. Pipeline Products by Therapy Area 13
Antares Pharma, Inc. Number of Pipeline Products by Trial Phase 14
Antares Pharma, Inc. Pipeline Products by Trial Phase 14
Antares Pharma, Inc. Number of Pipeline Products By Milestone Summary 15
Antares Pharma, Inc. Pipeline Products by Milestone Summary 16
Pen 1 - Product Status 17
Pen 1 - Product Description 17
Pen 2 - Product Status 18
Pen 2 - Product Description 18
Vibex EPI - Product Status 19
Vibex EPI - Product Description 19
VIBEX MTX - Product Status 20
VIBEX MTX - Product Description 20
VIBEX MTX - Product Milestone 20
VIBEX MTX - Results of VIBEX MTX Usability Study 21
VIBEX MTX - Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX MTX Auto-Injector Device 22
VIBEX MTX - Patent Details1 23
VIBEX MTX - Patent Details2 24
VIBEX MTX - Patent Details3 24
VIBEX MTX - Patent Details4 25
VIBEX MTX - Patent Details5 25
VIBEX MTX - Patent Details6 26
Vibex QST - Product Status 27
Vibex QST - Product Description 27
Vibex QST - Product Milestone 27
Vibex QST - Patent Details1 28
Antares Pharma, Inc., Key Employees 30
Antares Pharma, Inc., Key Employee Biographies 31
Antares Pharma, Inc., Subsidiaries 32

List of Chart


Antares Pharma, Inc. Pipeline Products by Equipment Type 8
Antares Pharma, Inc. Pipeline Products by Development Stage 10
Antares Pharma, Inc. Pipeline Products by Therapy Area 12
Antares Pharma, Inc. Pipeline Products by Trial Phase 14
Antares Pharma, Inc. Pipeline Products by Milestone Summary 15

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top